Clinical Trial Update: Bezafibrate Trial in CPT2 Deficiency [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of bezafibrate for Carnitine palmitoyltransferase II deficiency is mentioned, but the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carnitine Palmitoyltransferase Ii Deficiency

Drugs mentioned

• Bezafibrate (bezafibrate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Carnitine Palmitoyl Transferase 2 Deficiency | Phase 3 | Status: UNKNOWN